Also known as intensification therapy, consolidation chemotherapy is a type of ongoing treatment given to cancer patients who appear to be in remission. The goal of this type of cancer therapy is to kill off any residual cancer cells that may be present, effectively increasing the potential of a complete recovery. The dosage of the chemotherapy is usually somewhat high, allowing the treatments to be highly effective.
Consolidation therapy is used with many different forms of cancer. The treatment series can be utilized with patients who have achieved a remission from ovarian cancer, leukemia, or just about any other form of the disease. In some treatment processes, such as with the treatment of acute leukemia, consolidation chemotherapy is a follow-up to the induction therapy that is administered in an attempt to kill the cancer cells. If the induction therapy proves to be successful and the patient responds favorably, then consolidation is initiated in the hopes of helping the patient remain in a state of remission.
The process of using consolidation chemotherapy for ovarian cancer is similar, in that the patient undergoes a series of chemotherapy treatments once it appears that the cancer cells are no longer growing or spreading. By administering the treatments, it is sometimes possible to save the remaining ovary, thus allowing the woman the option of bearing children at some future point in time.
Not every cancer patient is a candidate for consolidation chemotherapy. The primary qualification is the measurable presence of remission with the form of cancer that the patient is experiencing. Until health care professionals confirm the remission, other types of cancer treatment are continued in an effort to bring the condition under control. This includes the use of radiation, lower doses of chemotherapy, and even surgery. In addition to being in remission, the attending physician must also determine that the patient is strong enough to manage the rigorous course of treatments that are involved with consolidation chemotherapy. Depending on the general well being of the patient, the treatment series may be a relatively short one, or take place over a period of several weeks before it is considered complete.
As with any chemotherapy series, the patient undergoing the treatments is likely to experience some side effects. Many patients report bouts of fatigue, loss of hair, and a change in the ability to taste food and drink. Some also report the appearance of flu like symptoms, including a stuffy nose, sneezing, and coughing. These side effects are often controlled with medication, and eventually fade away once the treatment series is completed.
